Related Experiment Videos
Current approach to malignant mesothelioma of the pleura
1Department of Medicine, University of Medicine and Dentistry of New Jersey, Robert-Wood Johnson Medical School, Cancer Institute of New Jersey, New Brunswick, USA.
Abstract:
Malignant mesothelioma of the pleura occurs primarily in individuals who were exposed to asbestos either in the workplace or home. The incidence of malignant mesothelioma is rising and, reflective of the malignancy's long latency period, is expected to continue to increase into the next century. Current treatment measures, including surgery, radiation therapy, chemotherapy, intrapleural therapy, and combined-modality therapies, have had varying impacts on survival. This paper explores current trends in the treatment of malignant pleural mesothelioma.
Insights
Malignant pleural mesothelioma, often linked to asbestos exposure, is increasing. This review examines current treatment strategies for this asbestos-related cancer, highlighting their varying survival impacts.
Area of Science:
- Oncology
- Environmental Health
Background:
- Malignant mesothelioma of the pleura is strongly associated with asbestos exposure.
- The incidence of malignant mesothelioma is rising and projected to increase due to its long latency period.
Purpose of the Study:
- To explore current trends in the treatment of malignant pleural mesothelioma.
Main Methods:
- Literature review of current treatment modalities.
- Analysis of surgical, radiation, and chemotherapy approaches.
- Examination of combined-modality and intrapleural therapies.
Main Results:
- Current treatments for malignant pleural mesothelioma include surgery, radiation, chemotherapy, intrapleural therapy, and combined-modality approaches.
- These treatments have demonstrated varying impacts on patient survival.
Conclusions:
- Understanding treatment trends is crucial for managing the increasing incidence of malignant pleural mesothelioma.
- Further research into optimizing therapeutic strategies is warranted.